Biomed Diagnostics, a DCN Dx Brand.’s Post

Our parent company, DCN Dx, will be exhibiting at MEDICA in Düsseldorf, Germany, from Nov. 11-14, 2024! Visit DCN's team of experts at our booth D25-2 in Hall 3 to explore their IVD CDMO and CRO services— including lateral flow assay development, industrial product design and device engineering, clinical research, and manufacturing. At the DCN Dx booth, attendees can also experience the miniDxR, a state-of-the-art customizable lateral flow assay reader. Designed by DCN Dx as an extension of its contract lateral flow assay development services, the miniDxR offers advanced imaging technology, superior sensitivity and specificity, and robust cybersecurity features—ideal for point-of-care testing. Request a meeting with DCN Dx at MEDICA: https://hubs.ly/Q02T96Xh0 We also welcome you to attend DCN Dx's talk on "Navigating U.S. Market Entry: Leveraging IVD Service Providers for Compliance and Device Integration," presented by Dr. Patrick Vaughan, Ph.D., COO of DCN Dx. The event will take place Nov. 11, 11:45 a.m. - 12:05 p.m. local time, in Hall 8A, Booth G40. We look forward to seeing you there! #MEDICA #MEDICA2024 #LateralFlow #LFA #AssayDevelopment #IVDCRO #IVDCDMO #DiagnosticsDevelopment #RapidTesting #RapidTest #Immunoassay #POCT #ClinicalResearch

  • No alternative text description for this image
Jack Shuang Hou

Scientific Director, Clinical Researches & Regulatory Affairs, In last six months of 2024, we got EUA 230055, EUA 240006, and K240728

1mo

Bis dann! CorDx

Like
Reply

To view or add a comment, sign in

Explore topics